Piper Sandler downgraded Assurant from Overweight to Neutral and set a new price target of $185.00 from $205.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | $223.00 | Neutral → Overweight | Piper Sandler |
| 2/20/2025 | $212.00 → $230.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 12/5/2024 | $251.00 | Equal-Weight | Morgan Stanley |
| 8/22/2024 | $200.00 | Overweight → Neutral | Piper Sandler |
| 2/12/2024 | $170.00 → $182.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 6/13/2023 | $144.00 | Neutral → Overweight | Piper Sandler |
| 3/21/2023 | $52.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 11/3/2022 | $199.00 → $151.00 | Outperform → Mkt Perform | Keefe Bruyette |
Piper Sandler upgraded Assurant from Neutral to Overweight and set a new price target of $223.00
Keefe Bruyette upgraded Assurant from Mkt Perform to Outperform and set a new price target of $230.00 from $212.00 previously
Morgan Stanley initiated coverage of Assurant with a rating of Equal-Weight and set a new price target of $251.00
8-K - ASSURANT, INC. (0001267238) (Filer)
8-K - ASSURANT, INC. (0001267238) (Filer)
SCHEDULE 13G - ASSURANT, INC. (0001267238) (Subject)
4 - ASSURANT, INC. (0001267238) (Issuer)
4 - ASSURANT, INC. (0001267238) (Issuer)
4 - ASSURANT, INC. (0001267238) (Issuer)